Showing results (181-190 of 310) with videos related to
Sort By:
Pageof 31
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|April 14, 2017
Methylglyoxal and Advanced Glycation End Products in Patients with Diabetes - What We Know so Far and the Missing LinksJan Benedikt Groener, Dimitrios Oikonomou, Ruan Cheko, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2010
Considerations in using US-based laboratory toxicity tables to evaluate laboratory toxicities among healthy malawian and Ugandan infantsIrene R Lubega, Mary Glenn Fowler, Philippa M Musoke, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2008
Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan childrenPhilippa M Musoke, Alicia M Young, Maxensia A Owor, et al.The Journal of Infectious Diseases|June 9, 2005
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012Tamara Flys, Dwight V Nissley, Cassidy W Claassen, et al.Drug and Alcohol Dependence|July 8, 2014
Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and ThailandGregory M Lucas, Alicia Young, Deborah Donnell, et al.The Journal of Infection|July 13, 2006
Demographic characteristics and risk behaviors associated with HIV positive injecting drug users in Xinjiang, ChinaYuanzhi Zhang, Hua Shan, Jennifer Trizzino, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|September 26, 2009
Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: Findings from two perinatal HIV prevention trials in Kampala, UgandaCarolyne Onyango-Makumbi, Danstan Bagenda, Antony Mwatha, et al.International Journal of Molecular Sciences|September 16, 2018
Protective Actions of Anserine Under Diabetic ConditionsVerena Peters, Vittorio Calabrese, Elisabete Forsberg, et al.Redox Biology|April 21, 2025
Endogenous acrolein accumulation in akr7a3 mutants causes microvascular dysfunction due to increased arachidonic acid metabolismXin Zhang, Johannes Gschwind, Vanessa Erben, et al.Clinical Neuroradiology|January 29, 2025
Intradermal Advanced Glycation End-products Relate to Reduced Sciatic Nerve Structural Integrity in Type 2 DiabetesChristoph M Mooshage, Dimitrios Tsilingiris, Lukas Schimpfle, et al.Pageof 31